Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 581 Neoplasms 486 Prostatic Neoplasms 309 Lung Neoplasms 240 Colorectal Neoplasms 202 Motor Activity 131 Carcinoma, Non-Small-Cell Lung 117 Brain Neoplasms 112 Uterine Cervical Neoplasms 111 Pancreatic Neoplasms 108 Head and Neck Neoplasms 106 Carcinoma, Hepatocellular 100 Stomach Neoplasms 99 Rectal Neoplasms 97 Ovarian Neoplasms 86 Colonic Neoplasms 86 Neoplasm Metastasis 67 Multiple Myeloma 65 Esophageal Neoplasms 65 Urinary Bladder Neoplasms 61 Hematologic Neoplasms 61 Glioblastoma 60 Sarcoma 58 Precursor Cell Lymphoblastic Leukemia-Lymphoma 58 Melanoma 58 Endometrial Neoplasms 55 Glioma 53 Lymphoma 50 Gastrointestinal Neoplasms 49 Leukemia, Myeloid, Acute 48

Interventions

Darbepoetin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recruiting × Primary Care × Clear all

NCT07130487 2025-11-25

Project CARE: CAncer Risk Evaluation

Rutgers, The State University of New Jersey

Phase NA Recruiting

Primary Care

Data powered by HemOnc (CC BY 4.0) Colophon ⚡